These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 14689685)

  • 1. [Does streptokinase still have a role in the treatment of acute myocardial infarct?].
    Janousek S
    Vnitr Lek; 2003 Nov; 49(11):880-4. PubMed ID: 14689685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombolytic treatment of acute myocardial infarct. 1].
    Soares-Costa JT; Soares-Costa TJ; Gabriel HM
    Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter clinical trial using an accelerated streptokinase regimen in patients with acute myocardial infarction.
    Xu C; Zhang T
    Chin Med J (Engl); 2000 Aug; 113(8):733-6. PubMed ID: 11776059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential cost effectiveness of tissue plasminogen activator among patients previously treated with streptokinase.
    Massel D
    Can J Cardiol; 1999 Feb; 15(2):173-9. PubMed ID: 10079776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of the kinin system as an alternative method of prevention or reduction reperfusive damages within thrombolytic therapy in patients with acute myocardium infarction.
    Korotkov A; Kistauri A; Korotkova A; Jibladze M; Guchua E
    Georgian Med News; 2006 Nov; (140):54-62. PubMed ID: 17179590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience with primary coronary angioplasty in management of patients suffering from acute myocardial infarction].
    Maslov LN; Krylov AL
    Angiol Sosud Khir; 2008; 14(1):131-41. PubMed ID: 19156043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombolytic treatment in acute myocardial infarction. Choice of preparations in Norwegian hospitals].
    Andreassen AK; Gullestad L; Endresen K
    Tidsskr Nor Laegeforen; 1998 Jun; 118(17):2630-1. PubMed ID: 9673511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pretreatment antistreptokinase antibody and streptococcal infection on the efficacy and dosage of streptokinase in acute myocardial infarction.
    Abuosa AM; Akhras F; Sorour K; El-Said G; El-Tobgy S; Kinsara AJ
    Saudi Med J; 2005 Jun; 26(6):934-6. PubMed ID: 15983677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrinolytic treatment of acute myocardial infarction (author's transl)].
    Woitinas F; Begemann H
    Herz; 1981 Feb; 6(1):50-4. PubMed ID: 7216122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New thrombolytic agents. Effect on the organization of care in myocardial infarction].
    Castaigne A; Duval-Moulin AM; Dubois Rande JL; Hervé C
    Ann Cardiol Angeiol (Paris); 1987 Dec; 36(10):577-81. PubMed ID: 3434985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selecting a thrombolytic agent.
    White HD
    Cardiol Clin; 1995 Aug; 13(3):347-54. PubMed ID: 7585772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The characteristics of thrombolytic therapy in myocardial infarct in middle-aged and elderly patients].
    Teslia AN; Kolesnikov SA; Mikhaĭlov AA
    Voen Med Zh; 1999 Jul; 320(7):40-4. PubMed ID: 10484919
    [No Abstract]   [Full Text] [Related]  

  • 14. Lingual hematoma due to streptokinase in a patient with acute myocardial infarction.
    Kaya A; Ordu S; Albayrak ES; Aydin M; Erden I; Ozhan H
    Am J Emerg Med; 2010 Oct; 28(8):985.e1-2. PubMed ID: 20825845
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiovascular pharmacology (XIII). The efficacy of different thrombolytic drugs in the treatment of acute myocardial infarct].
    López-Sendón J; López de Sá E; Bobadilla JF; Rubio R; Bermejo J; Delcán JL
    Rev Esp Cardiol; 1995 Jun; 48(6):407-39. PubMed ID: 9324694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Streptokinase--yes or no--a black and white view].
    Dvorák K
    Vnitr Lek; 2003 Nov; 49(11):842-4. PubMed ID: 14689679
    [No Abstract]   [Full Text] [Related]  

  • 17. [Streptokinase-induced jaundice].
    Gómez Guindal JA; Roldán Rabadán I; Perea Egido J; Jurado López JA; García de Frutos A; Martín Jadraque L
    Rev Esp Cardiol; 1999 Nov; 52(11):1025-7. PubMed ID: 10611814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Repeat thrombolysis in acute myocardial infarction].
    Sychra M
    Vnitr Lek; 2002 Aug; 48(8):791-3. PubMed ID: 12425212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic failure with streptokinase in acute myocardial infarction using electrocardiogram criteria.
    Lee YY; Tee MH; Zurkurnai Y; Than W; Sapawi M; Suhairi I
    Singapore Med J; 2008 Apr; 49(4):304-10. PubMed ID: 18418522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.